Dundee biotech outlook sees ‘ample room for upside’
January 18, 2010 by leonardzehr · Leave a Comment
While we were at the J.P. Morgan Healthcare Conference in San Francisco last week, Dundee Securities issued its latest biotech sector update. On the bright side, analyst David Martin writes that there are signs Biovail, Angiotech and QLT stocks are bouncing back – supported by new strategies and new products in development for each company. [...]
Listen to BioTuesdays 
